Del Re M.; Fogli S.; Derosa L.; Massari F.; De Souza P.; Crucitta S.; Bracarda S.; Santini D.; Danesi R., The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide, «CANCER TREATMENT REVIEWS», 2017, 55, pp. 71 - 82 [articolo]
Di Nunno V.; Cubelli M.; Massari F., The role of the MET/AXL pathway as a new target for multikinase inhibitors in renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2017, 2, pp. 169 - 175 [articolo]
Ciccarese C.; Massari F.; Blanca A.; Tortora G.; Montironi R.; Cheng L.; Scarpelli M.; Raspollini M.R.; Vau N.; Fonseca J.; Lopez-Beltran A., Tp53 and its potential therapeutic role as a target in bladder cancer, «EXPERT OPINION ON THERAPEUTIC TARGETS», 2017, 21, pp. 401 - 414 [articolo]
Giunchi, Francesca; Ciccarese, Chiara; Montironi, Rodolfo; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo, Urinary biomarkers for prostate cancer, «CURRENT DRUG METABOLISM», 2017, 18, pp. 0 - 0 [articolo]
Montironi R.; Gasparrini S.; Cimadamore A.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Moch H.; Montorsi F.; Scarpelli M., Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View, «EUROPEAN UROLOGY. SUPPLEMENTS», 2017, 16, pp. 232 - 240 [articolo]
Montironi R.; Cimadamore A.; Massari F.; Montironi M.A.; Lopez-Beltran A.; Cheng L.; Montorsi F.; Scarpelli M., Whole slide imaging of large format histology in prostate pathology: Potential for information fusion, «ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE», 2017, 141, pp. 1460 - 1461 [articolo]
Fiorentino, M; Gruppioni, E; Massari, F; Giunchi, F; Altimari, A; Ciccarese, C; Bimbatti, D; Scarpa, A; Iacovelli, R; Porta, C; Virinder, S; Tortora, G; Artibani, W; Schiavina, R; Ardizzoni, A; Brunelli, M; Knuutila, S; Martignoni, G, Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach, «ONCOTARGET», 2017, 8, pp. 7328 - 7335 [articolo]
Ciccarese C.; Massari F.; Tortora G., 2015 and human cancer: Back to overall survival, «FUTURE ONCOLOGY», 2016, 12, pp. 1751 - 1754 [articolo]
Ciccarese C.; Santoni M.; Brunelli M.; Buti S.; Modena A.; Nabissi M.; Artibani W.; Martignoni G.; Montironi R.; Tortora G.; Massari F., AR-V7 and prostate cancer: The watershed for treatment selection?, «CANCER TREATMENT REVIEWS», 2016, 43, pp. 27 - 35 [articolo]
Massari F.; Modena A.; Ciccarese C.; Pilotto S.; Maines F.; Bracarda S.; Sperduti I.; Giannarelli D.; Carlini P.; Santini D.; Tortora G.; Porta C.; Bria E., Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2016, 98, pp. 254 - 263 [articolo]
Diminutto A.; Basso U.; Maruzzo M.; Morelli F.; De Giorgi U.; Perin A.; Fraccon A.P.; Lo Re G.; Rizzi A.; Sava T.; Fornarini G.; Valcamonico F.; Zustovich F.; Massari F.; Zanardi E.; Roma A.; Zattoni F.; Zagonel V., Adjuvant Carboplatin Treatment in 115 Patients with Stage i Seminoma: Retrospective Multicenter Survey This study was presented at the 10th Genitourinary ASCO Symposium, San Francisco (US), Jan 30 to Feb 1, 2014, «CLINICAL GENITOURINARY CANCER», 2016, 14, pp. 161 - 169 [articolo]
Montironi R.; Santoni M.; Cheng L.; Lopez-Beltran A.; Massari F.; Matrana M.R.; Moch H.; Scarpelli M., An overview of emerging immunotargets of genitourinary tumors, «CURRENT DRUG TARGETS», 2016, 17, pp. 750 - 756 [articolo]
Conteduca V.; Crabb S.J.; Scarpi E.; Hanna C.; Maines F.; Joyce H.; Fabbri P.; Derosa L.; Massari F.; Lolli C.; Zarif S.; Jones R.J.; Caffo O.; Elliott T.; De Giorgi U., Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer, «MOLECULAR DIAGNOSIS & THERAPY», 2016, 20, pp. 255 - 263 [articolo]
Ciccarese C.; Massari F.; Tortora G., Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?, «EUROPEAN UROLOGY», 2016, 69, pp. 969 - 970 [articolo]
Ciccarese C.; Santoni M.; Massari F., Chemohormonal therapy in hormone-sensitive prostate cancer, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2016, 374, pp. 286 - 287 [articolo]
